A-201 - Role of the COVID-19 pandemic on the incidence and stage at initial diagnosis of cutaneous melanoma: a retrospective national study from the French Clinical Database of Melanoma Patients (RIC-Mel)

Autor: Skowron, F., Seigneurin, A., Mouret, S., Khammari, A., Charles, J., Leccia, M.-T., RIC-Mel Network

Publikováno v: In EJC Skin Cancer 2024 2 Supplement 1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment.

Autor: Tzoumpa S; Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France., Villette B; Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France.; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France., Granel-Brocard F; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; Department of Dermatology & Allergology, University Hospital of Nancy, Nancy, France.; RIC-Mel Network, France., Dutriaux C; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; Department of Dermatology, Saint-André Hospital, University Hospital of Bordeaux, Bordeaux, France., Memmi A; Department of Radiology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France., Jeudy G; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; Department of Dermatology, F. Mitterrand University Hospital, Dijon, France., Tafani V; Department of ENT, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France.; Department of ENT, Intercommunal Hospital Group Le Raincy Montfermeil, Montfermeil, France., Saint-Jean M; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; Department of Medical Oncology, Institut de Cancérologie de l'Ouest (ICO) - Site de Nantes/Saint-Herblain, Saint-Herblain, France., Nardin C; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; Department of Dermatology, University Hospital of Besançon, Besançon, France., Funck-Brentano E; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; Department of Dermatology, Ambroise-Paré University Hospital, AP-HP, Boulogne-Billancourt, France., Corre YL; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; Department of Dermatology, University Hospital of Angers, Angers, France., Quereux G; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; Department of Dermatology, CHU Nantes, Nantes University, INSERM, CNRS, Immunology & New Concepts in ImmunoTherapy, INCIT, Nantes, France., Maubec E; Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France.; French Group of Cutaneous Cancers (Groupe de Cancérologie Cutanée - GCC), France.; RIC-Mel Network, France.; INSERM UMR1124, Université Paris Cité, Paris, France.

Publikováno v: Immunotherapy [Immunotherapy] 2024; Vol. 16 (16-17), pp. 1029-1037. Date of Electronic Publication: 2024 Sep 13.